Structure, Activation, and Biology of Calpain

Diabetes

Volumn 53, Issue SUPPL. 1, 2004, Pages

  Suzuki, Koichi ^a,c   Hata, Shoji ^b   Kawabata, Yukiko ^b   Sorimachi, Hiroyuki ^b  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Pioneering Research Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALPAIN; CALPAIN 10; UNCLASSIFIED DRUG;

CALCIUM SIGNALING; CONFERENCE PAPER; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; DOWN REGULATION; GENE ACTIVATION; GENE DISRUPTION; GENE EXPRESSION; GENE STRUCTURE; GENETIC TRANSCRIPTION; MOLECULAR CLONING; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN HYDROLYSIS; SIGNAL TRANSDUCTION; X RAY ANALYSIS;

EID: 0842328803     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.2007.s12     Document Type: Conference Paper

References (44)

1. Saido TC, Sorimachi H, Suzuki K: Calpain: new perspectives in molecular diversity and physiological, pathological involvement. FASEB J 8:814-822, 1994
2. Sorimachi H, Ishiura S, Suzuki K: Structure and physiological function of calpains. Biochem J 328:721-732, 1997
3. Carafoli E, Molinari M: Calpain: a protease in search of a function? Biochem Biophys Res Commun 247:193-203, 1998
4. Sorimachi H, Suzuki K: The structure of calpain. J Biochem 129:653-664, 2001
5. Huang Y, Wang KKW: The calpain family and human disease. Trend Mol Med 7:355-362, 2001
6. 2+-dependent protease activity and a novel mode of enzyme activation. EMBO J 18:6880-6889, 1999
7. Strobl S, Fernandez-Catalan C, Braun M, Huber H, Masumoto H, Nakagawa K, Irie A, Sorimachi H, Bourenkow G, Bartunik H, Suzuki K, Bode W: The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc Natl Acad Sci U S A 97:588-592, 2000
8. 2+ switch align the active site of calpain. Cell 108:649-660, 2002
9. Reverter D, Strobl S, Fernandez-Catalan C, Sorimachi H, Suzuki K, Bode W: Structural basis for possible calcium-induced activation mechanism of calpains. Biol Chem 382:753-766, 2001
10. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pastuard P, Roudaut C, Hillaire D, Passos-Bueno M, Zatz M, Tischfield JA, Fardeau M, Jackson CE, Cohen D, Beckmann JS: Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81:27-40, 1995
11. Hirokawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PEH, del Bosque-Plata L, Hirokawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175, 2000
12. Ono Y, Shimada H, Sorimachi H, Richard I, Saido TC, Beckmann JS, Ishiura S, Suzuki K: Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem 273:17073-17078, 1998
13. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen G-Q, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus C: A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106:R69-R73, 2000
14. Permutt MA, Bernal-Mizrachi E, Inoue H: Calpain 10: the first positional cloning of a gene for type 2 diabetes? J Clin Invest 106:819-821, 2000
15. 2+-binding domain. J Biol Chem 273:15879-15822, 1998
16. 2+-regulated phospholipid-binding domain. Biochem Biophys Res Commun 280:1333-1339, 2001
17. 2-like domain. J Biol Chem 276:7404-7407, 2001
18. Yoshizawa T, Sorimachi H, Tomioka S, Ishiura S, Suzuki K: Calpain dissociates into subunits in the presence calcium ions. Biochem Biophys Res Commun 208:376-383, 1995
19. Pal GP, Elce JS, Jia Z: Dissociation and aggregation of calpain in the presence of calcium. J Biol Chem 276:47233-47238, 2001
20. Wang KKW, Nath R, Posner A, Rase KD, Burokev-Kilgore M, Hajimohammadreza I, Robert AW, Marcoux FW, Ye Q, Tankano E, Hatanaka M, Maki M, Caner H, Collins JL, Fergus A, Lee KS, Lunney EA, Hays SJ, Yuen P: An alpha-mercaptoacrylic acid derivative is a selective non-peptidic cell-permeable calpain inhibitor and is neuroprotective. Proc Natl Acad Sci U S A 93:6687-6692, 1996
21. Tompa P, Mucsi Z, Orosz G, Friedrich P: Calpastatin subdomains A and C are activators of calpain. J Biol Chem 277:9022-9026, 2002
22. 2+-dependent cysteine protease. FEBS Lett 501:111-114, 2001
23. Suzuki K, Sorimachi H, Yoshizawa T, Kimbara K, Ishiura S: Calpain: novel family members, activation and physiological function. Biol Chem 376:523-529, 1995
24. Nakagawa K, Masumoto H, Sorimachi H, Suzuki K: Dissociation of m-calpain subunits after autolysis of the N-terminus of the catalytic subunit, and is not required for activation. J Biochem 130:605-611, 2001
25. Shiraha H, Glading A, Chou J, Jia Z, Wells A: Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol 22:2716-2727, 2002
26. Arthur JS, Elce JS, Hegadorn C, Williams K, Greer PA: Disruption of the murine calpain small subunit gene, capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 20:4474-4481, 2000
27. Zimmerman U-JP, Boring L, Park JH, Mukerjee N, Wang KKW: The calpain small subunit gene is essential: its inactivation results in embryonic lethality. Life 50:63-68, 2000
28. Azam M, Andrabi SS, Sahr KE, Kamath L, Kulipoulos A, Chisti AH: Disruption of the mouse u-calpain gene reveals an essential role in platelet function. Mol Cell Biol 21:2213-2220, 2001
29. Spencer MJ, Guyon JR, Sorimachi H, Potts A, Richard I, Chamberlain J, Dalkilic I, Kunkel LM, Beckmann JS: Stable expression of calpain 3 from a muscle transgenic mice suggests a role for calpain 3 in muscle maturation. Proc Natl Acad Sci U S A 99:8874-8879, 2002
30. Sorimachi H, Kinbara K, Kimura S, Takahashi S, Ishiura S, Sasagawa N, Sorimachi N, Shimada H, Tagawa K, Maruyama K, Suzuiki K: Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem 270:31158-31162, 1995
31. Yoshikawa Y, Mukai H, Hino F, Asada K, Kato I: Isolation of two novel genes, down regulated in gastric cancer. Jpn Can Res 91:459-463, 2000
32. Benetti R, Del Sal G, Monte M, Paroni G, Bancolini C, Schneider C: The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis. EMBO J 20:2702-2714, 2001
33. Patel YM, Lane MD: Role of calpain in adipocyte differentiation. Proc Natl Acad Sci U S A 96:1279-1284, 1999
34. Patel YM, Lane MD: Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. J Biol Chem 275:17653-17660, 2000
35. Wang KKW, Yuen P-W: Calpain inhibition: an overview of its therapeutic potential. Trend Pharm Sci 15:412-419, 1994
36. Bartus RT, Hayward NJ, Elliott PJ, Sawyer SD, Baker KL, Dean RC, Akiyama A, Straub JA, Harbeson SL, Li Z, Powers J: Calpain inhibitor AK295 protects neurons from focal brain ischemia: effects of postocculusion intra-arterial administration. Stroke 25:2265-2270, 1994
37. Sokol SD, Kuwabara PE: Proteolysis in Caenorhabditis elegans sex determination: cleavage of TRA-2A by Tra-3. Genes Dev 15:901-906, 2000
38. Ma H, Fukiage C, Kim YH, Duncan MK, Reed NA, Shih M, Azuma M, Shearer TR: Characterization and expression of calpain 10. J Biol Chem 276:28525-28531, 2001
39. Braun C, Engel M, Theisinger B, Welter C, Seifert M: CAPN 8: Isolation of a new calpain-isoenzyme. Biochem Biophys Res Commun 260:671-675, 1999
40. Ortho-Malender M, Klannemark M, Svensson MK, Ridderstrale M, Lidgren CM, Groop L: Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid level. Diabetes 51:2658-2664, 2002
41. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kragen EW, White MF, Shulman GI: Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48:1270-1274, 1999
42. Itani S, Zhou Q, Pories WJ, MacDonald KG, Dohm GL: Involvement of protein kinase C in human skeletal muscle resistance and obesity. Diabetes 49:1353-1358, 2000
43. Sreenan SK, Zhou Y-P, Otani K, Hansen PA, Currie KPM, Pan C-Y, Lee J-P, Ostrega DM, Pugh W, Horikawa Y, Cox NJ, Hanis CL, Burant CF, Fox AP, Bell GI, Polonsky KS: Calpain plays a role in insulin secretion and action. Diabetes 50:2013-2020, 2001
44. Barnoy S, Supino-Rosin L, Kosower N: Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability. Biochem J 351:413-420, 351